These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1322566)

  • 1. Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
    Boyle TJ; Tamburini M; Berend KR; Kizilbash AM; Borowitz MJ; Lyerly HK
    Surgery; 1992 Aug; 112(2):378-86. PubMed ID: 1322566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
    Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
    Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
    Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
    Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV-induced human B cell lymphomas in hu-PBL-SCID mice.
    Mosier DE; Picchio GR; Kirven MB; Garnier JL; Torbett BE; Baird SM; Kobayashi R; Kipps TJ
    AIDS Res Hum Retroviruses; 1992 May; 8(5):735-40. PubMed ID: 1325170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse.
    Gan R; Yin Z; Liu T; Wang L; Tang Y; Song Y
    Cancer Sci; 2003 Sep; 94(9):796-801. PubMed ID: 12967478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cyclosporine on human B-cell lymphoma development in vivo.
    Boyle TJ; Coles RE; Kizilbash AM; Lyerly HK
    Surg Oncol; 1992 Feb; 1(1):79-86. PubMed ID: 1341239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas.
    Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT
    Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
    Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A
    Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma.
    Boyle TJ; Berend KR; DiMaio JM; Coles RE; Via DF; Lyerly HK
    Surgery; 1993 Aug; 114(2):218-25; discussion 226. PubMed ID: 8393595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human-->mouse radiation chimera do not develop Epstein-Barr virus lymphoma.
    Marcus H; Burakova T; Shezen E; David M; Canaan A; Lubin I; Reisner Y
    Immunol Lett; 1996 Mar; 49(3):155-61. PubMed ID: 8739310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
    Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
    J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
    Baiocchi RA; Caligiuri MA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
    Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
    Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras.
    Tang Y; He R; Zhang Y; Liu F; Cheng A; Wu Y; Gan R
    Virol J; 2011 May; 8():213. PubMed ID: 21554672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas.
    Zhang Y; Peng X; Tang Y; Gan X; Wang C; Xie L; Xie X; Gan R; Wu Y
    J Med Virol; 2016 Oct; 88(10):1804-13. PubMed ID: 26991077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.
    Tang Y; Lu S; Gan X; Liu F; Zhang Y; Luo C; Pan Y; Hong L; Gan R
    Oncol Rep; 2016 Feb; 35(2):905-11. PubMed ID: 26548532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.
    Garnier JL; Cooper NR; Cannon MJ
    Am J Pathol; 1993 Feb; 142(2):353-8. PubMed ID: 7679547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Model of B immunoblastic lymphomas in the Hu-PBL-SCID mice].
    Chen DQ; Bai LJ; Liu QF; Cui LX; He W; Ba DN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):294-6. PubMed ID: 12905742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
    Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
    J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.